Trial Profile
Aspirin + clopidogrel +/- either esomeprazole or ranitidine in patients with stable coronary artery disease
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 27 Dec 2011
Price :
$35
*
At a glance
- Drugs Clopidogrel (Primary) ; Esomeprazole (Primary) ; Aspirin; Ranitidine
- Indications Coronary artery disease; Embolism and thrombosis; Gastrointestinal disorders
- Focus Pharmacodynamics
- 27 Dec 2011 New trial record
- 01 Nov 2011 Results published in Thrombosis Research.